Simply Credit Help – Debt and Bad Credit Improvement Advice
dispute

Gilead ordered to pay Merck $200 million in hepatitis C drug patent dispute

March 26, 2016 by · Leave a Comment 

SAN JOSE, Calif.,/NEW YORK (Reuters) – A federal jury on Thursday ordered Gilead Sciences Inc to pay Merck & Co $200 million in damages for infringing two Merck patents related to a lucrative cure for hepatitis C. The damages award is far less than the $2 billion Merck had demanded. On Tuesday, the same jury in San Jose, California, upheld the validity of the patents, which

Here is the original post:
Gilead ordered to pay Merck $200 million in hepatitis C drug patent dispute